Compulsory License On Table In UK For Orkambi
The UK government will consider all options to improve access to Vertex’s cystic fibrosis treatment, including compulsory licensing.
You may also be interested in...
Prime Minister Boris Johnson has until 19 October to agree a deal, or otherwise must ask for another Brexit extension. But he's in no mood to follow the rules.
The UK’s main opposition party says it would use compulsory licensing to ensure access to “extortionately” priced medicines. Unsurprisingly, the responses are polarized.
Payments have now been made under the UK’s 2019 pricing and access to branded medicines scheme, but industry will have to wait longer for promises on access to materialize.